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1. Introduction 
Lymphoid malignancy is a remarkable disease because of its difference in epidemiology and 
etiology in different areas around the world. Several features of the epidemiology  
of lymphoid malignancy particularly stand out. The overall lymphoid malignancy incidence 
in Asian countries is relatively low. Histopathologic subtypes of lymphoma are different  
in eastern and western countries and generally similar among Asian countries.  
Differences in geographic distribution are striking for follicular lymphoma, which is  
less common in eastern countries than elsewhere. Asians have higher rates of aggressive 
NHL (Non-Hodgkin Lymphoma), T-cell lymphomas, and extra-nodal disease. Hodgkin's 
Lymphoma (HL) is relatively rare in Asian countries, and its subtypes are various in 
comparison with other areas. 
While for most cancers incidence and mortality are decreasing, the incidence rates of all 
subtypes of NHL have increased during the second half of the twentieth century, but the 
reason is poorly understood. This rise has been noted worldwide, in both genders, 
particularly in the elderly, and increase in high-grade NHL is predominant. Increase in NHL 
may be attributed to immunodeficiency, radiation, various infections, blood transfusion, 
familial aggregation, genetic susceptibility to NHL, chemical exposures to pesticides and 
solvents, and diet. Some studies also suggest that association between risk factors and 
specific NHL subtypes may be stronger than association between the same risk factors and 
NHL in aggregate. In addition the mentioned risk factors are different in various areas; 
therefore it may cause different distribution of lymphoid malignancy around the world. 
Geographic variation in lymphoma rate suggests the importance of environmental and gens 
effects. Risks for developing NHL include immunosuppression a causal link between 
infectious agents and lymphomagenesis, which have also been determined, particularly for 
human T-cell leukemia/lymphoma virus type1 (HTLV-1), Epstein– Barr virus (EBV), Helicobacter 
pylori infections and Hepatitis C Viruses (HCV)infection, which are relatively frequent in our 
area. In addition to the incidence of non-Hodgkin’s lymphoma and its histological subtypes 
in Asian migrants to the United States which is lower in first-generation migrants, 
confirmed this suggestion. Other exogenous factors which have been implicated in 
lymphomagenesis, mentioned earlier, are used more without any protection in developing 
countries. They may play an important role in these differences. 
In this chapter we compare our findings with the data from other relevant studies available 
in literature from various parts of Asia, as well as with those of Western countries in an 
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attempt to gain more insights into the differences between the Oriental and Western 
countries. In addition, because most different are related to etiologic factors, we also 
describe some of them. 
2. Non-Hodgkin Lymphoma  
Non-Hodgkin lymphoma is a heterogeneous group of B-cell and T-cell neoplasm that arise 
primarily in the lymph nodes with varied clinical and biologic feature. Current classification 
system include the Revised European-American Lymphoma (REAL) classification and the 
World Health Organization (WHO) classification of hematopoietic and lymphoid neoplasms 
(Alexander, et al., 2007). The distribution of NHL types varies internationally (Anderson, 
Armitage, & Weisenburger, 1998). Epidemiological investigation of the NHL and its etiology 
may result in a better understanding and hence prevention.  
2.1 Descriptive epidemiology  
Based on World Health Organization (WHO) classification,36 subtype of NHL (21 of B-cell 
and 15 of T-cell type) are recognized (Ekström-Smedby, 2006). NHL is the most common in 
the developed world, with the highest incidence in USA, Australia and New Zealand, and 
Europe, and the lowest in eastern and South central Asia (Ekström-Smedby, 2006). The age 
standardized incidence of NHL, around the year 2000, was estimated at approximately 10-
14 per 100000 person-year in western countries, and 3 per 100000 in South central Asia 
(Parkin, Bray, Ferlay, & Pisani, 2005). 
In recent decades, there has been a dramatic increase in NHL incidence worldwide, of about 
2-4% annually (Baris & Zahm, 2000). This increase has been occurred in both males and 
females in all age groups except the very young and in black and whites (Weisenburger, 
1994). Racial differences have not been observed in age-specific incidence curves until the 
age of 45 for males and 35 for females, however over these ages, NHL develops more 
frequently in whites than blacks (Müller, Ihorst, Mertelsmann, & Engelhardt, 2005). The 
highest increase was observed in western countries, but this increase is no limited to these 
countries, and it has been observed in eastern countries such as India, Japan, Singapore 
(Devesa & Fears, 1992). Several reasons including: recategorisation of borderline type of 
lymphoma; less histopathological misdiagnosis of NHL as Hodgkin's disease; greater use of 
immunohistological techniques to examine cancer of uncertain cell type and coding effects, 
may account for part of the increase (A. J. Swerdlow, 2003). The general trends in western 
countries has been a dramatic increase in incidence in young men in areas where AIDS has 
become common (Morton, et al., 2006). 
The median age of NHL in Asian countries is significantly lower, compared to the 
population-based registration in western countries. The Hematological Malignancy 
Research Network reported that the median age of their patients was 68 years old (Smith, et 
al., 2010). However the median age in Asian countries is about 54 years old, in Iranian 
patients was 55 years old (Mozaheb, Aledavood, & Farzad, 2011), in the Korean patients 52 
years (Y.-H. Ko, et al., 1998), in Taiwan 54 years (Lee, Tan, Feng, & Liu, 2005), and in a 
previous study in Japan 54.5 years (Aozasa, et al., 1985), but in a recent study in Japan it was 
66 years (Aoki, et al., 2008). It is notable that the median age of Asian patients at the time of 
presentation was younger than in the western countries and it might be attributable to the 
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lower frequency of lymph node type lymphoma, and higher frequency of T-cell lymphoma, 
which comes as follows. 
Geographically related variation in the incidence of histopathologic distribution and clinical 
feature of NHL are well recognized (Shih & Liang, 1991). T-cell leukemia lymphoma occurs 
more frequently in southwest Japan, and the Caribbean basin (Takatsuki, 1990), northeast of 
Iran (Mashhad) (Abbaszadegan, et al., 2003); follicular lymphoma (FL) occurs less frequently 
in eastern countries (Intragumtornchai, et al., 1996; Mozaheb, et al., 2011; Ohshima, 
Suzumiya, & Kikuchi, 2002), and Immunoproliferative Small Intestinal Disease (IPSID) is the 
most prevalent in the Middle east and Africa (Khojasteh & Haghighi, 1990).  
2.1.1 Immunologic characterization of non-Hodgkin's lymphoma  
Although B-cell lymphomas are constantly more common around the world, T-cell 
lymphomas are proportionally more common in Asia than in western countries (Müller, et 
al., 2005). Despite a higher percentage of T-cell lymphomas in Asians compared with 
westerns, the absolute incidences of T-NHL in HTLV1 non endemic areas, and western 
countries are quite similar when calculated by age-adjusted incidence (Aoki, et al., 2008; Au, 
et al., 2005; Wang, Young, Win, & Taylor, 2005). In a Chinese (non endemic area for HTLV1) 
study T-cell lymphoma proportion was 28.1% (Wang, et al., 2005), and also in Taiwan which 
is not endemic for HTLV1, T/NK lymphoma incidence was 12.4% (Lee, Tsou, Tan, & Lu, 
2005). In an Indian study T-cell lymphomas formed 16.2% of the total NHL (Naresh, 
Srinivas, & Soman, 2000). Previous Japanese studies have reported a higher proportion of T-
cell lymphoma, accounting for approximately 32-38% of non-Hodgkin lymphoma (Kadin, 
Berard, Nanba, & Wakasa, 1983; Pathologists, 2000), but the recent findings in Japan show 
the decreased frequency of T/NK cell lineage (25%) (Aoki, et al., 2008). In endemic area for 
HTLV1 in Japan, T/NK-cell neoplasm accounted for a higher percentage of lymphoid 
neoplasm, in Kyushu (30%) and Okinawa (38%), compared with other areas of Japan (18–
20%) (Aoki, et al., 2008). In one study in 1997 in Korea, in comparison with data reported in 
1992, the proportion of T-lineage lymphoma was markedly decreased (25%). At that time, 
the T-lineage of lymphoma accounted for 35.2% of malignant lymphomas (Y. H. Ko, et al., 
1998). It may be due to an increase in the frequency of B-cell lymphoma and an actual 
decrease in T/NK-cell, but the real reason remains unclear (Y. H. Ko, et al., 1998). 
2.1.2 Histological subtype of non-Hodgkin's lymphoma  
Diffuse Large B Cell Lymphoma. Among B-cell lymphomas, diffuse large B cell lymphoma 
(DLBCL) is the most common non-Hodgkin’s Lymphoma representing approximately one 
third of all Non-Hodgkin’s Lymphomas worldwide. This is one type of Non Hodgkin’s 
Lymphoma in which the relative incidence does not seem to vary geographically (Mozaheb, 
et al., 2011). In almost all parts of the world this is the most frequent occurring non-
Hodgkin’s lymphoma (K. E. Hunt & Reichard, 2008). In some studies like a recent study in 
Mashhad, Iran (Mozaheb, et al., 2011) there was a higher rate of aggressive NHL specially, 
diffuse large B cell lymphoma which occurs more frequent than others. It may be related to 
the etiology of diffuse large B cell lymphoma such as immune deficient conditions and their 
treatments which in most instances caused aggressive non-Hodgkin’s lymphoma, and we 
should consider that a comparative excess of DLBCL resulting in a deficit of follicular 
lymphoma. In addition genetic factors may have an important role in this difference. 
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Moreover it can represent the progression/transformation (referred to as secondary) of a 
less aggressive lymphoma, such as follicular lymphoma, marginal zone B-cell lymphoma, or 
nodular lymphocyte–predominant Hodgkin’s lymphoma (K. E. Hunt & Reichard, 2008). All 
lymphoid cancers are more frequent in males than females among all age groups and in our 
study Diffuse large B cell lymphoma occurs about twice among men (Mozaheb, et al., 2011). 
This pattern suggests that the underlying environmental or behavioral factors are also 
important and must be more common in men. The most common subtypes of NHL in 
Various Geographic Locations are showed in table 1. 
Follicular Lymphoma. Incidence rates of follicular lymphoma (FL) inexplicably vary 
markedly between Asian and Western countries (Biagi & Seymour, 2002). Follicular 
lymphoma was found more frequently in North America and Europe compared to other 
geographic sites (Kim, et al., 1992). The lowest rates of follicular lymphoma have been 
reported among Asian population (Anderson, et al., 1998; Mozaheb, et al., 2011). In addition, 
the risk was lower for the first generation of migrants from China and Japan into the US in 
comparison with the subsequent migrant generations, and in Japanese-Americans in Hawaii 
it was reported to be relatively high compared with that for native Japanese and close to the 
rate of North American Caucasians (Yanagihara, Blaisdell, Hayashi, & Lukes, 1989). The 
percentage of follicular lymphoma in our study in Mashhad, IRAN, was the lowest 
observed in any site (1.4%) (Mozaheb, et al., 2011), it was near the incidence rate of NHL in a 
previous study in Korea (1.6) (Y. H. Ko, et al., 1998). Although the exact reason for this 
difference is unknown, the results of several studies suggest differences in genes and 
environmental factors such as diet habits, infections and smoking, which plays an important 
role in follicular lymphoma, are responsible. Some cytogenetic changes such as a higher 
incidence of bcl-2 translocations are seen within follicular lymphoma among individuals in 
the US than for Asian populations (Shih & Liang, 1991). It conclude that a significant 
gradient exists in the bcl-2 frequency between these FL populations, and therefore suggest 
that the relatively low incidence of FL in Asian populations is caused not by a lower 
frequency of bcl-2 rearrangements in healthy populations but by distinct molecular 
pathways developing in different geographic regions that nonetheless culminate in FL, 
which is morphologically similar but molecularly distinct (Biagi & Seymour, 2002). 
In a previous study in Japan the incidence rate of FL was 6.7% (Pathologists, 2000), but in a 
recent study in Japan they found a relatively high rate of FL (19%) similar to that of western 
countries (11-30%) (Aoki, et al., 2008). They suggest the following reasons for the relatively 
high rate of occurrence of follicular lymphomas. First, there have been improvements in the 
recognition and diagnostic accuracy for this subtype due to the development of 
comprehensive diagnostic methods including flow cytometry, immunohistochemistry, 
chromosome testing, gene testing and FISH. Second, the patients in their recent study 
comprised only initial visit cases and did not include consultation cases, because typical 
follicular lymphoma tends to be diagnosed at the initial visit and not during consultation, 
previous studies of patients in large hospitals may not have included initial visit cases and 
thus underestimated the frequency of follicular lymphoma. The third reason is the 
westernization of the Japanese lifestyle that may have contributed to an increase in follicular 
lymphoma (Aoki, et al., 2008). The rate of follicular lymphoma for Japanese– Americans in 
Hawaii was reported to be relatively high compared to that of native Japanese and close to 
the rate of North American Caucasians. A similar trend in completely follicular lymphoma 
has been reported for Korea. In one study in 1997 compared with the data reported in 1991, 
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the increase in the relative frequency of Fl (1.6% vs 6.4%) over time suggests that the 
patterns of malignant lymphoma occurrence in the Republic of Korea might be gradually 
changing, probably due to westernization and other reasons which were mentioned 
previously (Y. H. Ko, et al., 1998). 
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2010 1991/1997 2000/2006 2000 2005 2004 2000/2008 1991 2001 2006 
Total (No) 391 1165/1548 ----/598  447 1983 3025/2260 9567 10580  
NHL % 92 94.7/94.7 ----/93 2831 82.6% 92.1% 94/7/92.7  84.4  
B/T cell %  75/25 81.7/18.3 80.6/19.4 79/15.2 68.6/30.6 75/25 
68/24, 
65.2/25.4 76/24 93/7 90/10 
DLBCL % 37.8 -/43.2 47.2/39 34 35.1 50.5 33/33 41.2 41.3 28 
FL % 1.4 1.6/6.2 8.6/16.4 12.6 8.6 8.4 6.7/18.2 9.2 17 13 
MCL % 2.2 -/1.5 ----/4 3.4 2.6 1.5 2.7/2.7  3.7 2 
MALT 
lymphoma% 
2.2 -/0.6 6.1/5.6 8.2 11.7 5.5 8.4/4.2 8.7 3.6 3.7 
SLL/CLL % 23.9 -/2.3  5.6 3.6 3.4 1.4/1.4   20 
NK/T cell 
lymphoma % 




1.9 -/9.4 19.3/3.8 1.9 12 13.1 6.6/4.5 9.7 5.9 6 
ATLL % 1.4 -/0.1  rare rare  7.4/10  rare rare 
HL % 8 5.3/5.3 ----/7  13.9 7.9 4.4/7.3  15.6 8 
Table 1. The Most Common subtypes of NHL in Various Geographic Locations 
In the analysis of 1983 cases of malignant lymphoma in Thailand shows that Bangkok has a 
significantly high frequency of FL, much higher than that the Central region. They suggest 
that the underlying reason for this observation is not known. Obviously, Metropolitan 
Bangkok has a more diverse population, migrated from various geographical locations, than 
people in the Central region (Sukpanichnant, 2004). A clinicopathological analysis of 598 
Malignant Lymphomas in Taiwan during the period of 1995–2002 was retrieved, and their 
data showed a similar incidence of FL (16.4%) to that in Western countries (Lee, Tan, et  
al., 2005).  
Mantle cell Lymphoma (MCL) in a case series has been between 2 and 10% of all NHL. The 
incidence rate is approximately similar around the world (table 1) and it is about 0.5 cases 
per 100000 person-year, with male to female ratio 2.3-2.5:1, and a median age at diagnosis is 
about 70 years. Relative association of MCL risk with Borrelia burgdorferi infection, family 
history of hematopoietic malignancies, and genetic variation in the interleukin 10 and tumor 
necrosis factor genes have been reported, but finding remain unconfirmed (Smedby & 
Hjalgrim., 2011).  
www.intechopen.com
 
 Epidemiology Insights 
 
330 
T cell lymphomas are very complicated, based on WHO classification, there are various 
subtypes, and different types of them are different in various area of the world and some are 
extremely rare, occurring in a few patients per year throughout the world. Major T cell NHL 
types were reported in the international study in about 1300 patients 22 sites in different 
countries. Based on this study the most common subtype of T cell lymphoma in North 
American (NA) was PTCL (unspecified), in Europe was Angioimmunoblastic T cell 
lymphoma (AITL), and in Asia was Natural Killer T cell lymphoma (NKTCL) and ATLL 
(Foss, et al., 2011). This variation may reflect exposure or genetic susceptibility to pathogenic 
agents such as EBV and HTLV1 in Asian countries. Table 2 showed the major T cell subtype 
of NHL in different area (Vose, et al., 2008). 
 
% PTCL AITL Anaplastic NKT CL ATLL 
NA 34.4 16 23.8 5.1 2 
Europe 34.3 28.7 15.8 4.3 1 
Asia 22.4 17.9 5.8 22.4 25 
Table 2. Major subtype of T cell lymphoma by region 
Generally speaking an increasing incidence in lymphoma reported from western countries is 
also seen in Asia, albeit at a lower rate (Shih & Liang, 1991).Essential differences in the 
incidence and distribution of major NHL subtypes among different geographic areas were 
seen which seems to be related to host, racial and environmental differences (Atichartakarn, 
et al., 1982), but these differences gradually changes in recent reports, this shows that the 
environmental factors probably are more important than the genes. 
2.1.3 Extra-nodal non-Hodgkin Lymphoma  
Non-Hodgkin lymphoma arises in lymphatic cell in other organs except lymphatic tissues, 
called extra-nodal lymphoma. Some authors believe that, specific local factors may play an 
etiologic role in the development of lymphomas at certain extra-nodal sites e.g., 
Helicobacter pylori infection is associated with primary gastric lymphoma, but not with 
lymphoma at other sites (Parsonnet, et al., 1994b; Wotherspoon, et al., 1993). There are 
geographical and ethnic differences in the incidence of extra-nodal lymphomas (Newton, 
Ferlay, Beral, & Devesa, 1997). 
The frequency of primary extra-nodal NHL in Asia Varied from 28.5 to 45% (Shih & Liang, 
1991), it is similar to Europe, but slightly more common than united states: Denmark 37% 
(d'Amore, et al., 1991), India 22% (Advani, et al., 1990), Hawaii-Japanese 34% (Yanagihara, et 
al., 1989), Lebanon 44% (P. Salem, et al., 1986), Chinese Hong Kong 28% (Ho, Todd, Loke, 
Ng, & Khoo, 1984), USA 25% (Freeman, Berg, & Cutler, 1972), Italy 48%, East Germany 47% 
(Newton, et al., 1997). 
The incidence of extra-nodal NHL in Western countries has increased substantially in the 
last 40 years. This may be due to improved diagnostic procedures (particularly in 
gastrointestinal and brain lymphomas) and changes in classification systems, but the change 
is real and the AIDS epidemic in the 1980s does not completely explain this rise (Groves, 
Linet, Travis, & Devesa, 2000). The etiology of extra-nodal lymphomas appears to be 
multifactorial and includes immune suppression, infections both viral and bacterial, and 
exposure to pesticides and other environmental agents (Zucca, 2008). True geographic 
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differences are, however, present for example, the incidence of Epstein–Barr virus and 
human T-cell lymphotropic virus 1-associated with T-cell lymphomas is higher in Asia than 
in Europe and North America (Zucca, 2008). 
One study, which was done in 39 centers in 14 countries (USA, Europe, Asian) reported the 
most frequent extra-nodal sites of lymphoma are stomach and skin, followed by small 
intestine and tonsil (Newton, et al., 1997). In recent study extra-nodal lymphoma in Japan, 
was seen in 27% of cases, but in previous Japanese series it was 60% (Izumo, 1996). DLBCL 
was the most common type of extra-nodal lymphoma lesion primarily biopsied/resected 
(60%). The ear–nose–throat region (7.2%), gastrointestinal tract (6.0%), soft tissue (2.8%) and 
skin (2.6%) was reported in Japanese study (Aoki, et al., 2008). A clinical analysis in 
Republic Korea revealed that the rate of extra-nodal lymphoma exceeded that of lymph 
node lymphoma (63.3% vs. 36.7%) (Y.-H. Ko, et al., 1998). As in other Far East countries, 
Korea has a relatively high rate of angiocentric lymphomas, which more than 70% of them 
arise in the nose and paranasal sinus. EBV was positive in 80% of nasal and paranasal 
angiocentric lymphomas. (Ko & Lee, 1994, 1996). In a study in Thailand, extra-nodal 
involvement was found in 1072 of 1826 cases (58.7%) of NHL. The frequency of B-cell NHL 
in cases of NHL involving extra-nodal sites was 72.9%, whereas the frequency of nodal B-
cell NHL was 78.0%. Thus, a higher frequency of T-cell NHL involving extra-nodal sites and 
a higher frequency of B-cell NHL involving lymph nodes were significant when compared 
to the overall NHL (P <0.05). In the Thailand study, among the extra-nodal sites involved in 
NHL, the upper aerodigestive tract (including the tonsils, sinonasal region, oral cavity, and 
nasopharynx) was the most common site. The second most common site was the 
gastrointestinal tract, including the stomach and intestine (Sukpanichnant, 2004). These 
studies shows that extra-nodal NK/T cell lymphoma is more prevalent in far east and is 
closely related to EBV infection (Jaffe, 1999; Jaffe, et al., 1996). 
Immunoproliferative small intestinal disease (IPSID) or α heavy chain disease is mostly 
found in young adults of low socioeconomic class in developing countries or in indigent 
immigrant population within western countries. Relatively high incidence rates of small 
intestinal lymphoma have been reported before in the Middle east, Mediterranean region, 
South and central Africa, Mexico, and South America, but is rare in Southeast Asia 
(Pramoolsinsap, Kurathong, Atichartakarn, & Nitiyanand, 1993). 
IPSID was one of the most common small intestinal malignancy in the Middle East (Azar, 
1962). Early infectious stress in infancy and chronic antigenic stimulation along with genetic 
factors are probably important in the pathogenesis of IPSID (Khojasteh, Haghshenass, & 
Haghighi, 1983). It showed that Campylobacter jejune were present in 5/7 cases of IPSID in 
one study and 12/27 (47%) cases in other and 14/87 (16%) cases of other intestinal 
lymphoma. Eradication of the organism with antibiotics lead to complete remission of IPSID 
(Du, 2007). 
In one series of 161 patients with IPSID in Shiraz (Iran), they observed a dramatic decrease 
in the incidence of the disease over the past decade. After the Islamic revolution in Iran, 
improving sanitation in villages was one of the priorities of the many health strategies in 
Iran. Access to sanitary drinking water in rural areas increased from 35% before 1988 to 80% 
a decade later. Vaccination programs increased dramatically after the Islamic revolution, 
reaching more than 90% of children. Local health facilities increased significantly during the 
first two decades after the revolution. They suggest that improvement of health in general 
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and decreasing childhood gastroenteritides in particular has resulted in a decrease in the 
incidence of IPSID. This report highlights the almost complete disappearance of a malignant 
disease from a region where it was once very common. This changes probably related to 
changes in environmental factors, decreasing exposure to infectious agents (Lankarani, et 
al., 2005). Other preliminary recent epidemiological data has also shown a decrease in the 
incidence of this disease in endemic areas; therefore, environmental factors are suspected to 
play an important role in its pathogenesis (P. A. Salem & Estephan, 2005).  
2.2 Epidemiologic etiology  
2.2.1 Immunodeficiency and autoimmune disease  
Immunodeficiency, including acquired conditions and congenital disease, is the strongest 
factor known to increase NHL risk (Chiu & Weisenburger, 2003). About 25% of patients 
with congenital immunodeficiency syndromes such as Wiskott-Aldrich syndrome, ataxia 
telangiectasia and severe combined immunodeficiency, will develop tumors during their 
lifetime, which NHL accounting for 50% of them. It seems that these patients unable to 
promptly eliminate respiratory and gastrointestinal pathogens due to defects in formation of 
specific protective antibodies and are susceptible to chronic antigenic stimulation 
(Filipovich, Mathur, Kamat, & Shapiro, 1992).  
High rate of NHL also have been observed among individual with iatrogenic 
immunosuppression (i.e. organ or blood stem cell transplantation recipients, long term 
survivors of Hodgkin's lymphoma), variety of autoimmune disease, and Acquired 
immunodeficiency syndrome (AIDS). Although immunosuppressive drug use in the 
treatment of these conditions may cause an increase in NHL incidence, evidence suggests 
that the persistent inflammatory activity of the autoimmune process may have a direct 
relation with increase risk of lymphomagenesis. One study showed that these conditions 
may be accompanied by impaired T-cell function, which interferes with an immune 
response to virus and emerging malignant cells. NHL due to secondary immunodeficiency 
is associated with the presence of EBV infection, and tumors are characterized by high grad, 
and proclivity for extra-nodal sites (Fisher & Fisher, 2004). Based on these data 
immunodeficiency may be more common in some area which aggressive lymphoma is more 
common such as Asian countries. 
Autoimmune disorders that are strongly associated with NHL are Sjogren’s syndrome, 
systemic lupus erythematosus (SLE), rheumatoid arthritis, and celiac disease (CD). There is 
no evidence to support excess risk of NHL in other autoimmune disorders. One study 
demonstrated a 25-fold increase in the risk of NHL among persons with highly 
inflammatory RA as compared to a similar group having low inflammatory disease; this risk 
was independent of treatment (Fisher & Fisher, 2004). Finding in the other study suggests 
that the excess risk of NHL in RA patients may be a result of the disease or its treatment, 
rather than shared genetic susceptibility (Ekström, et al., 2003; Kinlen, 1992). 
Celiac disease is an autoimmune digestive disease which is caused by an immune response 
to the protein gluten. Untreated CD is associated with increased risk of lymphoma, mostly 
with origins from gastrointestinal mucosa. The pathogenesis behind this association is not 
fully understood, but greater permeability to environmental carcinogenesis, release of 
proinflammatory cytokines , and chronic antigenic stimulation are among the suggested 
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mechanisms. Also a correlation between the duration of gluten exposure and the incidence 
of lymphoma has been found. The relative risk of lymphoma is reduced by a gluten free diet 
(Jafroodi, Zargari, & Hoda, 2009). In a US cohort study, an increased risk of NHL was 
reported in patients with celiac disease (SMR = 9.1, 95% CI: 4.7-13.0). Similarly, a relative 
risk of 5.8 (95% CI: 1.58-14.86) was observed in a UK cohort (Alexander, et al., 2007).  
The incidence of CD is increasing among certain populations in Africa (Saharawui 
population), Asia (India), and the Middle East (Cummins & Roberts Thomson, 2009). In 
Asian populations, including the Japanese, CD and the associated NHL have been supposed 
to be quite rare, and studies concerning the frequency of CD or its relationship with NHL 
are scarce. A Japanese case report describes a Japanese middle-aged man with intestinal 
diffuse large B-cell lymphoma associated with CD. Following multi-combined 
chemotherapy, the patient's lymphoma has received complete response, and his GI 
symptoms have improved with a gluten free diet (Makishima, et al., 2006). Also an Iranian 
case report describes a child with Hodgkin's disease and sever atopic dermatitis associated 
with CD (Arellano, et al., 2009). These cases suggest that the possibility of CD and its 
association with lymphoid malignancy should be kept in mind, even in Asian populations.  
2.2.2 Infectious agents  
Epidemiological studies pointed towards a viral and bacterial etiology on NHL. In this part 
we discuss about some of them which are more important. 
Epstein-Barr virus (EBV). The Epstein-Barr virus has a worldwide distribution, which 
greater than 80% of people over the age of 30 are infected. Once EBV infection has occurred, 
it remains for the lifetime of the individual (Serraino, et al., 2005). Infection with this virus 
usually occurs in children, but can also occur in adolescence or adulthood. EBV 
asymptomatically establishes persistent infections however, due to effective immune 
control, only a minority of infected carriers develop spontaneous EBV-associated lymphoma 
(Heller, Steinherz, Portlock, & Munz, 2007). Infection by EBV is more common in 
developing countries where sanitation, hygiene, and cooking are not as sterile as nations 
such as the USA (Evans & Kaslow, 1997).  
EBV has a unique set of genes that causes a growth activation of the B-cells that are infected. 
Sometime the growth activating genes may cause the infected B-cell to transform into cancer in 
certain people. The most common type of lymphoma caused by EBV are T-cell lymphoma, 
Post-transplant lymphoma, AIDS associated lymphoma, Burkitt's lymphoma (BL), and 
Hodgkin's lymphoma. These EBV-associated neoplasms are characterized by peculiar 
geographic distributions and distinctive epidemiologic features (Serraino, et al., 2005) . 
In the endemic areas of Africa, BL is the leading childhood cancer, occurring as many as 4-5 
cases per 100000. In areas where EBV infection occurs at a very early age and malaria is 
holoendemic, the incidence of association with BL is highest. In African countries in the 
lymphoma belt there is a very high association between BL and EBV (90%). However, in 
France and the US, the rare cases of BL are only associated with EBV in 10-15% of all 
reported cases (Frimpong-Boateng). 
Induced immunosuppretion, necessary for the transplant to be accepted, leads to a loss of 
control over EBV infection. The lymphoma that is developed contains parts of the latent 
EBV genome. About half of NHL tumors accompanying HIV1 infections are EBV positive. 
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These lymphoma are grouped into several categories: small non-cleaved-cell lymphoma, 
diffuse large cell lymphoma, anaplastic large cell lymphoma, and body-cavity based 
lymphoma (Gaidano, et al., 1996). 
Several studies showed the association of Asian T cell lymphoma and evidence of EBV 
infections. Asian T-cell lymphomas are different from Western T-cell lymphoma, and are 
also associated with increased levels of cytokine production, including tumor necrosis factor 
(Dutcher, 2003). Aggressive NK-cell LGL leukemia is usually a rapidly progressive disorder 
associated with EBV, with a higher prevalence in Asia and South America (Sokol & 
Loughran, 2006). 
Human T-Cell Lymphotrophic virus-1 (HTLV1). HTLV1, the first human retrovirus to be 
discovered, is estimated to infect 10-20 million people worldwide (De Thé & Bomford, 1993). 
Infection with HTLV1 is strongly related to adult T-cell leukemia/ Lymphoma (Hinuma, et 
al., 1981) and HTLV1 associated myelopathy (Morgan, Mora, Rodgers-Johnson, & Char, 
1989). HTLV1 is primarily transmitted by breast feeding, blood transfusion, Sharing of 
needles and sexual transmission. The predominance of vertical transmission results in 
clustering cases in familial or geographically discrete groups. It is endemic in southern 
Japan, the Caribbean, the Melanesian island, Papua New Guinea, the Middle East, central 
and southern Africa, and South America. In these endemic areas, seroprevalences range are 
different from about one percent in Mashhad in southeast Iran (1-3%) (Abbaszadegan, et al., 
2003; Tarhini, et al., 2009) to 30 percent in rural Miyazaki in southern Japan. In table 3 we 
can see the prevalence rate of HTLV1 in different countries. 
Population HTLV-I seroprevalence increases with age and is twice as high in females. In 
Jamaica 17·4% of women over 70 and 9·1% of men over 70 were seropositive. In Japan, 
HTLV-I seroprevalence in persons over 80 was 50% in females and 30% in males. This 
gender difference usually emerges after 30 years of age and may be related to more efficient 
transmission of the virus from males to females in the sexually active years (Yamaguchi, 
1994). Seroprevalence tends to increase with age and women are nearly twice as likely to be 
infected as men (Mueller, Okayama, Stuver, & Tachibana, 1996). 
HTLV1 shows little genomic variability during the course of infection and between patients 
in the same geographic area. Mother/child and spouse pairs from Okinawa (Japan) have 
been shown to be infected with highly conserved viruses upon direct sequencing of viral 
genome (Kakuda, Ikematsu, Chong, Hayashi, & Kashiwagi, 2002). Studies in France 
(Gessain, Gallo, & Franchini, 1992) the Solomon Islands (Nerurkar, Song, Saitou, Melland, & 
Yanagihara, 1993) and Zaire (LIU, et al., 1994) have shown similarly low genomic variability 
based upon the less accurate sequencing of PCR products. Therefore, small strain variation 
is recognized between geographic areas. Risk of infection is higher (fourfold increase) in 
breast fed infants than in those who are bottle fed (HIRATA, et al., 1992). A longer duration 
of breast feeding increase transmission risk (Li, et al., 2004). Another important risk factor is 
provirus load in breast milk. 
The infection is usually asymptomatic in the beginning and the disease typically manifests 
later in life; therefore silent transmission occurs. Since there are no prospects of vaccines and 
screening of blood banks and prenatal care settings are not universal, transmission is active 
in many areas such as parts of Africa, South and Central America, the Caribbean region, 
Asia, and Melanesia (Goncalves, et al., 2010). 
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country Sample size Prevalence of HTLV1 Group 
rural Miyazaki, 
southern Japan 
 Up to 30% General population 
Iran (Mashhad) 1653 2.1 General population 
Lebanon  3529 0.06 Blood donors 
Taiwan  3700000 0.06 Blood donors 
Korea 9281 0.13 Blood donors 
Jamaica  3-6% General population 
Caribbean  6% General population 
Curacao 2524 1.92% General population 
Papua New Guinea 1221 0-14.6% General population 
Argentina  2082 1.9% General population 
U.S 1700000 0.01 Blood donors 
Italy 14598 0.03 Blood donors 
Germany 100852 0 Blood donors 
U.K 570609 0.001 Blood donors 
Table 3. Prevalence of HTLV1 in different countries 
Adult T-cell lymphoma leukemia (ATL) is an aggressive lymphoproliferative malignancy, 
with short survival in its acute form and an incidence of less than 5% in HTLV-1-infected 
people (Shimoyama, 1991). The cumulative incidence of ATL among Japanese HTLV1 
carrier is about 2.5% (3-5% in male and 1-2% in female). Although women are more infected 
with HTLV1, but ATL is more common in men, it shows that other factors also should be 
responsible. At first ATL was described in Japan and later in the Caribbean region and 
South America (Uchiyama, Yodoi, Sagawa, Takatsuki, & Uchino, 1977). In the United States 
and Europe, ATL was diagnosed in immigrants from regions of endemicity. ATL occurs at 
least 20 to 30 years after the onset of HTLV-1 infection and is more common in adult males. 
Individuals infected in childhood may be at a higher risk of developing ATL (Pawson, et al., 
1998). The occurrence of ATL in the fourth decade predominates in Brazil and in Jamaica 
(Proietti, Carneiro-Proietti, Catalan-Soares, & Murphy, 2005), but in Japan, the fifth decade 
of life is predominant for the occurrence of ATL (Shimoyama, 1991). Possibly, local factors 
play a role in disease pathogenesis. 
Helicobacter pylori (H. pylori). Helicobacter pylori colonizes gastric mucosa, leading to chronic 
Gastric infection, and induce peptic ulcer disease and gastric carcinoma, also may cause B-
cell lymphomas, particularly mucosa-associated lymphoid tissue (MALT) tumors in the 
stomach, with the association being strongest in early lesion (Chiu & Weisenburger, 2003; 
Zucca, et al., 2000). In developing countries, where over 90% of the population may be 
infected, H. pylori infection usually occurs during childhood with chronic infection 
continuing throughout adulthood (Pounder & Ng, 1995). In contrast, although in developed 
countries the overall prevalence generally remains lower than in developing countries, the 
prevalence is low among children and rises with age in adults. H. pylori has been detected in 
more than 90% of patients with low-grade gastric MALT lymphoma, and in 40-75% of high-
grade gastric lymphomas (Boot & Jong, 2002). 
Direct fecal oral transmission is predominant in industrialized countries whereas other 
transmission routes such as contamination of water may be more important in developing 
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countries. The bacteria is transmitted within families in early childhood (Farinha & 
Gascoyne, 2005). Parsonnet et al. (Parsonnet, et al., 1994a) and Vineis et al. (Vineis, et al., 
1999) reported a significant positive association between H. pylori infection and risk of 
gastric NHL but not non-gastric NHL. Greater than 60% of MALT lymphomas regress with 
H. pylori eradication following treatment with antibiotics (R. Hunt, Sumanac, & Huang, 
2001). Because the US prevalence of H. pylori infection is low and declining, H. pylori most 
likely did not play a significant role in the overall rising trend of NHL incidence in the US 
(Alexander, et al., 2007). H. pylori infection is more common in Asian countries, therefore as 
we can see in table 1, MALT lymphoma in most Asian countries are more common than 
western countries. 
Hepatitis C Virus (HCV). Hepatitis C virus infection has been reported to be a prevalent 
disease since the second half of the 20th century (Strickland, 2006). Infection in different parts 
of Asia is similar, with an average seroprevalence of hepatitis C antibody less than 2.5% in 
the general population. The major routes of HCV transmission in Asia have been through 
blood transfusions and intravenous drug use, similar to the other countries. Other possible 
routes of transmission are medical intervention, tattooing, acupuncture, vertical and sexual 
transmission, accidental needle-stick and household contact. It is believed that HCV is still 
spreading in some areas of Asia because of the lack of routine screening of donated blood 
(Kao & Chen, 2000). HCV has been linked to lymphomagenesis in people with and without 
type II mixed cryoglobulinemia (Saadoun, Landau, Calabrese, & Cacoub, 2007). Increasing 
evidence indicates that the association between HCV infection and lymphoma may be due 
to viral infection related chronic antigenic stimulation. The chronic inflammation pathway 
would be consistent with the association between HCV and several types of lymphomas and 
with the regression of some lymphoma after eradicating the HCV infection (Hermine, et al., 
2002; Vallisa, et al., 2005). One study showed that the association between HCV infection 
and risk of NHL subtypes included mostly countries with low background HCV prevalence. 
This study showed increased risks of DLBCL, marginal zone lymphoma and 
lymphoplasmacytic lymphoma associated with HCV infection (De Sanjose, et al., 2008). 
Another study revealed that there is no association between NHL and HCV infection (King, 
Wilkes, & DIAZ ARIAS, 1998). Prevalence of HCV in series of patients with NHL in studies 
from different countries was various, it was more common in Italy and Japan (Armstrong, et 
al., 2006). Based on these studies there are marked regional differences in the prevalence of 
hepatitis C infection in non-Hodgkin lymphoma. It seems that other factors including 
genetics, race, hormonal, and immunologic factors are required for malignant 
transformation. Several studies showed the frequency was higher in older women. 
Lymphoma associated with HCV infection more frequently present as primary extra-nodal 
lymphoma, especially in the liver, spleen and salivary glands (Armstrong, et al., 2006). 
Human Immunodeficiency Virus (HIV). The relationship between human immunodeficiency 
virus/acquired immunodeficiency syndrome (HIV/AIDS) and the risk of developing NHL 
has been observed with strong positive associations in numerous studies. (Hooper, Holman, 
Clarke, & Chorba, 2001; Ragni, et al., 1993). The relative risk of NHL among persons infected 
with HIV has been reported to be over 100, (Coté, et al., 1997; Goedert, et al., 1998) with the 
greatest risk for B-cell lymphomas and high-grade histology (Coté, et al., 1997; A. Swerdlow, 
2003). Chronic antigenic stimulation and immune deficiency may be responsible for the 
increased risk of NHL among HIV-infected persons. HIV may act by inducing 
immunodysregulation, affecting genes responsible for cell regulation and failing to control 
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other viruses, which may result in opportunistic infection and replication of oncogenic 
viruses (Coté, et al., 1997). In AIDS patients NHL has been reported in approximately 2-3% 
of patients with AIDS, but AIDS accounts only for a small fraction of all NHL (Biggar & 
Rabkin, 1992; Rabkin & Yellin, 1994). In an international collaboration on HIV and cancer, 
incidence data from 23 prospective studies were used to compare incidence rates of NHL in 
HIV-infected persons in 1997–1999 with those in 1992–1996 (Coutinho, 2000). The incidence 
rates for NHL declined from 6.2 per 1,000 person-years to 3.6 per 1,000 person-years. 
Grulich et al. (Grulich, et al., 2001) reported a significantly lower relative risk of NHL in 
persons with HIV in the period of highly active antiretroviral therapy (HAART) availability 
than in the period immediately prior (RR = 0.58, 95% CI: 0.36–0.92) (Alexander, et al., 2007). 
In one study in Japan the incidence of AIDS-related lymphoma detected at autopsy was 
higher in Japan (27%) than in the US (12%). However, histological subtypes of AIDS-related 
lymphoma in Japan seem to be similar to those in western countries and DLBCL is also the 
most common subtype of AIDS-related lymphoma in Japan. A large number of AIDS-
related lymphoma cases were categorized into EBV-associated opportunistic lymphoma in 
Japan. The incidences detected by autopsy did not differ statistically between the pre-
HAART era and the HAART era (P = 0.31), and the histological subtype of DLBCL was 
stable in both the pre-HAART era (78%) and the HAART era (77%) . In contrast, they found 
an increase in patients with BL from 2% in the pre-HAART era to13% in the HAART era. 
(Hishima, et al., 2006). Despite the high rate of human immunodeficiency virus infection in 
Thailand, only 5 cases of documented AIDS-associated lymphoma were noted in one study 
(5 of 389 NHL; 1.3%). Similarly, Kaposi's sarcoma is not common in AIDS patients in 
Thailand. The underlying reason for this unique feature of AIDS-related lymphoma in 
Thailand is not known and further investigation is needed (Sukpanichnant, et al., 1998). In 
one study in India the proportional incidence ratio (PIR) for NHL was significantly 
increased in HIV era (PIR in males = 17.1, 95%CI 13.33-21.84, females = 10.3, 95%CI 6.10-
17.41), and their finding was similar to that reported by other studies (Dhir, et al., 2008). In 
one study in Singapore when comparing the age-standardized rates for males and female in 
1998 – 2002 which are 8.2 and 5.0 per 100,000 respectively compared with 7.5 and 4.4 per 
100,000 in 1993-1997 and 3.1 and 1.9 per 100,000 in 1968-1972, this may be partly due to 
HIV/AIDS, changes in pathological classification and improved diagnostic capabilities 
(Seow & Registry, 2004). Except for one study in Thailand, HIV/AIDS lead to increase 
incidence rate of lymphoma in both eastern and western countries. 
Human herpesvirus-8 (HHV-8). Human herpesvirus-8, is endemic in regions of the 
Mediterranean and Africa (Kamiyama, et al., 2004), but the seroprevalence of HHV-8 which 
has been studied in Malaysia, India, Sri Lanka, Thailand, Trinidad, Jamaica and the USA, in 
both healthy individuals and those infected with HIV, was found to be low in these 
countries in both the healthy and the HIV-infected populations (Ablashi, et al., 1999). HHV-8 
is generally accepted to be associated with development of primary effusion lymphoma 
(PEL), a rare B-cell lymphoma that almost exclusively affects HIV-positive patients (Ascoli, 
et al., 2002). However this lymphoma is often associated with both HHV-8 and EBV, limiting 
the understanding of the pathogenic role of HHV-8 (Ascoli, et al., 2002). Within B-cell 
lymphomas, however, HHV-8 infection was associated significantly and positively with risk 
of lymphoplasmacytic lymphoma (OR = 4.47, 95% CI: 1.34–14.85) or low-grade B-cell 
lymphoma and lymphoma not otherwise specified (OR = 5.82, 95% CI: 1.07-31.73) (Feuillard, 
et al., 1997). 
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Simian Virus 40 (SV40). Simian Virus 40 is the most well characterized member of the 
Polyomaviridae family, and is closely related to two human polyomaviruses (Poulin & 
DeCaprio, 2006).It induces an inapparent infections in immunocompetent hosts, but can 
produces pathologic effects in immunocompromised individuals through the destruction of 
infected cells (Imperiale, 2000).Simian virus 40, an agent that infects Asian ma- caques, 
contaminated the early poliovirus vaccines used in the United States, Europe, and other 
region during the mass immunization program for poliovirus in the late 1950 and early 1960 
(Strickler, et al., 2003). The Norwegian study shows that between 1953 and 1997, the 
incidence rate of lymphoproliferative diseases increased about 3-fold in both males and 
females (Thu, et al., 2006), and the other study report that polyomavirus SV40 is significantly 
associated with non-Hodgkin lymphoma in HIV-1-infected and HIV-1-uninfected patients 
and might have a role in the development of these hematological malignancies (Vilchez, et 
al., 2002). These observations suggest that polyomavirus SV40 might be causing infections in 
human beings long after the use of the contaminated vaccines. There is no documented 
study around it in Asian countries.  
2.2.3 Genetic factors and family history 
Family history and genetic factors increase risk of NHL in people whose relatives previously 
were diagnosed with NHL, but hereditary factors are hypothesized to account only for a small 
percentage of NHL and are unlikely to explain the increase in NHL incidence. Tumor 
suppressor genes, oncogenes and DNA repair genes may play a role in NHL carcinogenesis, 
and some genes may interact with environmental exposures that affect NHL risk (Fisher & 
Fisher, 2004). In a US multicenter case–control study, Chatterjee et. al showed (Chatterjee, et al., 
2004) the strongest associations were found among siblings (HR = 7.6, 95% CI: 0.98–58.8) and 
male relatives (HR = 6.2, 95% CI: 0.77–50.0) of NHL cases. For a parental history of 
histopathologically concordant lymphoma, the strongest associations with lymphoma risk 
among offspring were found for B-cell lymphoma (SIR = 11.8, 95% CI: 2.2–34.8) and follicular 
lymphoma (SIR = 6.1, 95% CI: 1.1–18.0) (Altieri, Bermejo, & Hemminki, 2005). 
Several genetic polymorphisms associated with the risk of NHL suggest that single 
nucleotide polymorphisms (SNPs) in tumor necrosis factor (TNF) and interleukin-10 (IL10) 
are associated with risk of NHL, especially diffuse large B –cell lymphoma. Relatively few 
studies have examined the potential interaction between germline susceptibility and 
environmental or lifestyle factors in the etiology of NHL (Alexander, et al., 2007). The 
mechanism (s) by which genetic predisposition or gene-environment interactions may 
enhance or reduce the risk of developing NHL remains a largely unexplored area of 
research (Alexander, et al., 2007).  
2.2.4 Lifestyle and personal and environmental factors 
Results from studies that evaluated lifestyle and personal factors are generally inconsistent, 
with few exceptions. Alcohol consumption appears to be inversely associated with NHL, 
based primarily on results from case–control studies (Chiu, et al., 1999; Chiu, et al., 2002). 
Further evidences from cohort studies are needed. Smoking does not appear to play an 
important role in the etiology of NHL overall; however, it has relation with follicular 
lymphoma (Bracci & Holly, 2005). Fish intake has been associated consistently with a 
nonsignificantly decreased risk of NHL in several studies (Zhang, et al., 1999), but intake of 
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omega-3 fatty acids from fish was not associated with reduced risk of NHL in one cohort 
study (Purdue, Bassani, Klar, Sloan, & Kreiger, 2004). Several but not all studies have 
reported positive association with red meat intake. Data are limited, and results have not 
been consistent, for estimates of associations with specific types of red meat or with 
preparation or cooking methods (Chang, et al., 2006; Ward, et al., 1994). Saturated fat intake 
was associated positively (Chang, et al., 2006), however vegetable consumption was 
associated inversely, with NHL risk in most studies (Chang, et al., 2005; Mozaheb & 
Aledawood, 2011). Biological mechanisms for these dietary factors have not been 
established. Neither obesity nor physical activity has been associated consistently with NHL 
(Alexander, et al., 2007). 
Certain workers have a slightly increased risk of developing NHL, including farmers; 
pesticide applicator; miller; meat worker; wood and forestry worker; chemists; painters; 
mechanics; printers; and worker in the petroleum, rubber, plastics, and synthetics industries 
(Alexander, et al., 2007). Some of these occupations are more common in Asian countries 
such as farmers, pesticide applicator, wood worker, worker in petroleum; on the other hand 
exposure is more because of low educational program in these places. Also There is 
significant relationship between hair dye use and NHL risk (Altekruse, Jane Henley, & 
Thun, 1999). 
3. Hodgkin's Lymphoma 
Hodgkin lymphoma is a neoplastic disease of the lymphoid tissue characterized by the present 
of multinucleated giant cell of B-cell origin, known as Red-Stenberg cell, in background of 
numerous reactive lymphocyte (Classical, 2009). HL is less common in Asians, especially at the 
young adult ages. There is incidence variation by age, social class, geographic location in HL. 
Thus, the comparison of HL rates in Asian and western countries could inform the relative 
importance of environmental factors and genetic to disease etiology.  
3.1 Descriptive epidemiology  
The epidemiology of Hodgkin's lymphoma is complex. Hodgkin Lymphoma demonstrates 
different histologic findings, clinical presentation, and outcome. Hodgkin's lymphoma is 
relatively uncommon, but at young adult ages it is one of the most common malignancies. 
Increasingly there is a great difference in incidence between developing and western 
developed countries. In developing countries, the disorder appear predominantly during 
childhood and its incidence decreases with age (Thomas, Re, Zander, Wolf, & Diehl, 2002). 
The annual age adjusted incidence rates of 2.8 and 2.4 per 100,000 in the USA and UK 
respectively (RiesLAG, HankeyBF, & HarrasA, 1994). 
Hodgkin's lymphoma has been reported to be rare in Asians. One study in the US from 2000 
to 2007, 16,710 cases of HL reported that black and Asians had low incidence (black/white 
incidence rate ratio (IRR) 0.86, P<0.01; Asian/White IRR 0.43, P<0.01). The bimodal pattern 
of incidence was less prominent for black males. Asian and black presented at a mean age of 
38 years compared to 42 years for Whites (P<.001) (Pareen, Alison, Neha, & Christopher, 
2010).There are few studies in exploring the relative contributions of environmental and 
hereditary etiology of Hodgkin's lymphoma, and individual risk factors in an Asian 
population. The other study which compared HL incidence rate in Japanese, Chinese, 
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Filipino, and Asian Indian in the US and in Asia reports HL incidence rates were quite low 
in all Asian subgroups but approximately double in US Asian. The consistently low rates of 
HL in Asians suggest genetic resistance to the disease development, possibly associated 
with HLA type. In addition environmental and lifestyle differences between the USA and 
Asia are important. In some study from Eastern Asia and among Chinese immigrants in 
North America indicate increasing incidence trends for HL being associated with 
westernization (Caporaso, Goldin, Anderson, & Landgren, 2009). International and inter-
ethnic differences and risk factor patterns in case-control data, implicate environmental 
influences in the etiology of HL (Glaser & Hsu, 2002). 
Incidence rate of HL are usually grater in male than in female (Correa & O'Conor, 1971). In 
western countries the young adult peak largely consist of nodular sclerosis tumors, whereas 
the rise at older ages are largely mixed cellularity and lymphocytic-depleted histology 
 (Spitz, et al., 1986). Hodgkin's lymphoma tends to be more common in young adult with 
higher socio-economic classes (Correa & O'Conor, 1971). Pattern of low social class 
determinants in children and older adult with HL, the age groups at risk for mixed 
cellularity (MC), support involvement of underling infectious agent given intense exposure, 
and EBV is a likely candidate based on its high prevalence in these groups (Glaser & Jarrett, 
1996). Based on different studies the most common subtype of HL in the most Asian 
countries such as Iran, Korea, Thailand, Japan is mixed cellularity and relative paucity of NS 
subtype, particularly in males (Glaser & Hsu, 2002), which seems to be related to the 
etiologic factors (environment and/or inheritance) of disease. Subtypes of HL in different 

















NS 10 (31.2) 26 (31.7) 58 (36.9) 29 (69) 70 (42.4) Up to 08 60 
MC 16 (50) 38 (46.3) 64 (40.8) 2 (4.7) 51 (31) <10 15 
LD 3 (9.3) 6 (7.3) 14 (8.9) 0 8 (5) 1 rare 
LP 1 (3.1) 4 (2.6) 18 (11.5) 2 (4.7) 18 (11) 6 10 
NLPHD 2 (6.3) 8 (9.8) 3 (1.9) 3 (7.1) 8 (5) 5 5 
Table 4. Subtypes of Hodgkin's disease in various countries 
A shift from MC-dominant histologic subtype of HL was observed over 20-year period 
within Japan, particularly in young adults (Aozasa, Ueda, Tamai, & Tsujimura, 1986).  
As NS and MC have been shown to have different environmental cofactors, including 
socioeconomic status and degree of EBV tumor-cell presence, geographic variation in HL 
is likely to reflect change in socioeconomically determined exposures whenever possible.  
3.2 Etiologic epidemiology 
The differences in descriptive epidemiology of Hodgkin's lymphoma between children, 
young adults and older adults may reflect differences in etiology between these age groups. 
3.2.1 Environment  
Infections. Systemic analysis of epidemiological data pointed towards an infectious agent as 
a potential cause for Hodgkin's lymphoma. Recognition of an association of infectious 
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mononucleosis with Hodgkin's disease predate the discovery of EBV (Richard F. Ambinder, 
2007). Investigators have reported that EBV infectious mononucleosis is associated with a 
lifelong "immunologic scar" (Sauce, et al., 2007). The statistical analysis suggested that HL 
tended to occur 2.9 years after infectious mononucleosis (R.F. Ambinder, 2007). Remarkably, 
the change in lymphocyte cell population is sustained over years or longer (Richard F. 
Ambinder, 2007). There are new insights into infectious mononucleosis and disturbances in 
cellular immunity, new insight relating to the role that viruses may play in molecular 
pathogenesis of HL, an emerging appreciation of the increased incidence of HL in HIV and 
its relationship to immune suppression (Richard F. Ambinder, 2007). A role for suppression 
T cell suggested in the 1970s, and increasing evidence shows a role for this cells in 
suppressing antitumor immune responses (Hjalgrim, et al., 2007). 
In western countries, about 50% of all cases of classical HL are EBV positive, means the 
virus is carried within the tumor cells. Detection of EBV in tumors in these region are least 
common in young adult disease. In some parts of Latin America, Africa, and Asia, the 
percentage is much higher with the percentage in children approaching 90- 100% (Glaser, 
et al., 1997; Zarate Osorno, Roman, Kingma, Meneses Garcia, & Jaffe, 1995). The MC 
subtype harboring EBV DNA in up to 70% of cases and the NS subtype being positive in 
15-30% of cases (Brousset, et al., 1991). Also detection of EBV in HL in most Asian 
countries are less in young adults and are more detectable in children and older ages. 
Because of these differences infectious cofactors other than EBV have been suggested, but 
no consensus in support of any other particular association have emerge (Wilson, et  
al., 2007). 
As we mentioned EBV induce immune suppression, and in an EBV positive person, MC 
subtype is more common (like HIV positive), therefore in MC subtype of HL, which is more 
common in Asian countries, immunodeficiency has more important role in comparison with 
other subtypes.  
HIV. Hodgkin's lymphoma in the setting of HIV has distinctive features and is usually 
associated with EBV infection (Glaser, et al., 2003). HL in patients with HIV tends to present 
at an advanced stage with associated B symptoms and extra-nodal involvement and is most 
often a mixed cellularity subtype. Model fitting suggested that for persons with AIDS with 
moderate immunosuppretion at the onset of AIDS, HL risk was 15-fold higher than in the 
general population. Lower CD4 counts were associated with less risk, the risk fall as CD4 
count fall (R.F. Ambinder, 2007).  
3.2.2 Inheritance 
The risk of developing HL among family member of patients affected by HL increase  
from three-to nine-fold (Haim, Cohen, & Robinson, 1982). One study showed a significant 
association between HL and parental consanguinity and pointed to the possible  
etiologic role of recessive inheritance (Abramson, Pridan, Sacks, Avitzour, & Peritz,  
1978). 
The relative risk for HL among first degree relatives of cases compared with controls was 
3.1. Relative risks were higher in males compared with females, and in siblings of cases 
compared with parents and offspring. Identifying inherited susceptibility genes is an 
important step towards defining the pathway leading to development of HL and 
www.intechopen.com
 
 Epidemiology Insights 
 
342 
understanding its etiology. There are many studies of somatic mutations in HL tumor cells, 
but although there are associations with HLA types, specific germline genes causing 
susceptibility have not yet been identified. On the other hand it is not known whether or 
how extrinsic risk factors interact with genetic susceptibility (Goldin, et al., 2005). 
Oza et al. in the single study of HL-HLA relationship found that HLA-DPB1*0301 inreased 
risk of HL in all ethnic groups, while HLA-DPB1*0401 was associated with a lowered risk of 
HL in Japanese and Chinese and an elevated risk for US whites and Israelis (Oza, et al., 
1994). Therefore; HLA-DPB1*1401, or factors related to it, could explain some of the lower 
incidence of HL in certain Asian ethnic groups, although environmental factors involves as 
well and indicate that HL etiology is complex. 
4. Conclusion 
There is evidence of etiologic heterogeneity among types of NHL, with different incidence 
patterns according to age, sex, race and specially geography. The extent to which these 
differences reflect differences in etiology needs further study.  
Epidemiologic studies indicate that environmental factors may play an important role in the 
etiology of non-Hodgkin's lymphoma. Given the recognition that transmissible agents, 
especially in the developing world, are a significant cause of some kind of lymphoma, 
focusing on effective strategies to prevent infection altogether will go a long way to 
diminish the lymphoma. Additionally, effective strategies for toxic and occupational 
exposure and changing global lifestyles will yield huge dividends. Future epidemiologic 
research on NHL will be enhanced by analyses of subtypes of NHL, improved reliability 
and validity of exposure assessment tools to evaluate occupational, environmental and 
personal exposures, and evaluation of susceptible subgroups of individuals whose risk of 
NHL may differ from that of the general population. Finding the relation between 
environmental factors and genes in lymphomagenesis also important and it needs more 
investigation. 
Lower rate of HL in Asians suggestive of genetic resistance, in addition international and 
inter-ethnic differences implicate environmental influence. Additional insight into the 
balance of genetic and environment factors on HL risk should be forthcoming. Differences 
in HL risk reported in several studies indicate that such studies of HL risk factors should be 
conducted for specific Asian population.  
Overall in developing countries the most common subtype of lymphoid malignancies both 
HL and NHL are those subtype which immunodeficiency have an important role in their 
pathogenesis. 
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